Published in

Elsevier, International Journal of Antimicrobial Agents, 2(44), p. 136-139

DOI: 10.1016/j.ijantimicag.2014.03.010

Links

Tools

Export citation

Search in Google Scholar

Combination therapy in the treatment of experimental invasive fungal infection by Sarocladium (Acremonium) kiliense

Journal article published in 2014 by Fabiola Fernández-Silva, Javier Capilla, Emilio Mayayo, Josep Guarro ORCID, Deanna Sutton
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

10.1016/j.ijantimicag.2014.03.010 ; Since human infections by Sarocladium (Acremonium) kiliense are usually refractory to antifungal therapy, combinations of drugs are an option that needs exploring. The antifungal activities of anidulafungin plus posaconazole or voriconazole and of amphotericin B plus voriconazole were evaluated and their efficacy was tested in a murine model of disseminated infection by three S. kiliense strains. The results showed that although efficacy was strain-dependent, these combinations work better, in general, than monotherapies. The best results were obtained with the combination of anidulafungin plus posaconazole, although the in vitro assay showed indifference or an antagonistic effect.